WallStSmart
OGI

OrganiGram Holdings Inc

NASDAQ: OGI · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$1.37
-2.14% today

Updated 2026-04-29

Market cap
$192.67M
P/E ratio
12.45
P/S ratio
0.69x
EPS (TTM)
$0.11
Dividend yield
52W range
$1 – $2
Volume
0.7M

OrganiGram Holdings Inc (OGI) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
Last 4 quarters
Revenue YoY growth
+48.6%
Most recent quarter
EPS YoY growth
+91.3%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-0.2%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-17.6%
2026-02-10
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-10$-0.01-80.0%$1.59$1.31-17.6%
2025-12-16$-0.28-3900.0%$1.80$2.11+17.2%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.01$-0.01-80.0%$63.49M+48.6%
2025-09-30$-0.01$-0.28-3900.0%$80.06M+79.1%
2025-06-30$-0.01$-0.05-257.1%$70.79M+72.4%
2025-03-31$-0.03$0.22+891.4%$65.60M+74.3%
2024-12-31$-0.02$-0.14-587.6%$42.73M+17.2%
2024-09-30$-0.04$-0.10-189.1%$44.70M-2.9%
2024-06-30$-0.07$0.03+142.9%$41.06M+25.2%
2024-03-31$-0.09$-0.26-188.9%$37.63M-4.7%
2023-12-31$-0.11$-0.14-35.7%$36.45M
2023-09-30$-0.02$-0.37-1501.7%$46.04M
2023-06-30$-0.05$-0.68-1260.0%$32.78M
2023-03-31$-0.02$-0.02+0.0%$39.49M

Frequently asked questions

Has OrganiGram Holdings Inc beaten earnings estimates?
OrganiGram Holdings Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports.
How does OGI stock react to earnings?
OGI stock has moved an average of -0.2% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is OrganiGram Holdings Inc's revenue growth rate?
OrganiGram Holdings Inc reported year-over-year revenue growth of +48.6% in its most recent quarter, with EPS growing +91.3% year-over-year.